IDENTIFICATION OF L-TRYPTOPHAN DERIVATIVES WITH POTENT AND SELECTIVE ANTAGONIST ACTIVITY AT THE NK1 RECEPTOR

被引：63

作者：

MACLEOD, M ^{[1
]}

MERCHANT, KJ ^{[1
]}

BROOKFIELD, F ^{[1
]}

KELLEHER, F ^{[1
]}

STEVENSON, G ^{[1
]}

OWENS, AP ^{[1
]}

SWAIN, CJ ^{[1
]}

BAKER, R ^{[1
]}

CASCIERI, MA ^{[1
]}

SADOWSKI, S ^{[1
]}

BER, E ^{[1
]}

STRADER, CD ^{[1
]}

MACINTYRE, DE ^{[1
]}

METZGER, JM ^{[1
]}

BALL, RG ^{[1
]}

机构：

[1] MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1994年 / 37卷 / 09期

关键词：

D O I：

10.1021/jm00035a006

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

As part of a program of screening the Merck sample collection, N-ethyl-L-tryptophan benzyl ester was identified as a weak antagonist at the substance P (NK1) receptor. Structure-activity studies showed that the indole ring system could be replaced by 3,4-dichlorophenyl, alpha- or beta-naphthyl, or benzthiophene with retention or only small loss of affinity. It was found that acylation of the tryptophan nitrogen gave compounds with higher affinity than N-ethyl or other basic amines. Optimization of substitution on the benzyl ester led to the identification of the 3,5-bis-(trifluoromethyl)benzyl ester of N-acetyl-L-tryptophan 26 as a potent and selective substance P receptor antagonist. Compound 26 blocked substance P induced dermal extravasation in vivo and was the most potent compound from this structurally novel class of antagonists which further adds to the diversity of small molecules that bind to the (NK1) receptor.

引用

页码：1269 / 1274

页数：6

共 29 条

[1]

CASCIERI MA, 1992, MOL PHARMACOL, V42, P458

[2]

CASCIERI MA, IN PRESS J BIOL CHEM

[3]

CHANG MM, 1970, J BIOL CHEM, V245, P4780

[4] DISCOVERY OF A POTENT SUBSTANCE-P ANTAGONIST - RECOGNITION OF THE KEY MOLECULAR DETERMINANT [J].

DESAI, MC ;

LEFKOWITZ, SL ;

THADEIO, PF ;

LONGO, KP ;

SNIDER, RM .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) :4911-4913

[5] PHARMACOLOGICAL PROFILE OF A HIGH-AFFINITY DIPEPTIDE NK1-RECEPTOR ANTAGONIST, FK888 [J].

FUJII, T ;

MURAI, M ;

MORIMOTO, H ;

MAEDA, Y ;

YAMAOKA, M ;

HAGIWARA, D ;

MIYAKE, H ;

IKARI, N ;

MATSUO, M .

BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) :785-789

[6] PHARMACOLOGICAL PROPERTIES OF A POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P ANTAGONIST [J].

GARRET, C ;

CARRUETTE, A ;

FARDIN, V ;

MOUSSAOUI, S ;

PEYRONEL, JF ;

BLANCHARD, JC ;

LADURON, PM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10208-10212

[7] STUDIES ON NEUROKININ ANTAGONISTS .3. DESIGN AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW BRANCHED TRIPEPTIDES N-ALPHA-(SUBSTITUTED L-ASPARTYL, L-ORNITHYL, OR L-LYSYL)-N-METHYL-N-(PHENYLMETHYL)-L-PHENYLALANINAMIDES AS SUBSTANCE-P ANTAGONISTS [J].

HAGIWARA, D ;

MIYAKE, H ;

MURANO, K ;

MORIMOTO, H ;

MURAI, M ;

FUJII, T ;

NAKANISHI, I ;

MATSUO, M .

JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (16) :2266-2278

[8] AN SAR STUDY FOR THE NONPEPTIDE SUBSTANCE-P RECEPTOR (NK1) ANTAGONIST, CP-96,345 [J].

HOWSON, W ;

HODGSON, J ;

RICHARDSON, R ;

WALTON, L ;

GUARD, S ;

WATLING, K .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (06) :559-564

[9] THE NATURE OF PI-PI INTERACTIONS [J].

HUNTER, CA ;

SANDERS, JKM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (14) :5525-5534

[10] AROMATIC AROMATIC INTERACTIONS - FREE-ENERGY PROFILES FOR THE BENZENE DIMER IN WATER, CHLOROFORM, AND LIQUID BENZENE [J].

JORGENSEN, WL ;

SEVERANCE, DL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (12) :4768-4774

← 1 2 3 →